These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10702797)

  • 1. Cooperative interaction between mutant p53 and des(1-3)IGF-I accelerates mammary tumorigenesis.
    Hadsell DL; Murphy KL; Bonnette SG; Reece N; Laucirica R; Rosen JM
    Oncogene; 2000 Feb; 19(7):889-98. PubMed ID: 10702797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors.
    Tzeng YJ; Zimmermann C; Guhl E; Berg B; Avantaggiati ML; Graessmann A
    Oncogene; 1998 Apr; 16(16):2103-14. PubMed ID: 9572491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of des(1-3) insulin-like growth factor 1 in the mammary glands of transgenic mice delays the loss of milk production with prolonged lactation.
    Hadsell DL; Torres DT; Lawrence NA; George J; Parlow AF; Lee AV; Fiorotto ML
    Biol Reprod; 2005 Dec; 73(6):1116-25. PubMed ID: 16079306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
    McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
    Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A transgenic mouse model for mammary carcinogenesis.
    Li B; Murphy KL; Laucirica R; Kittrell F; Medina D; Rosen JM
    Oncogene; 1998 Feb; 16(8):997-1007. PubMed ID: 9519874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2 expression delays mammary tumor development in dimethylbenz(a)anthracene-treated transgenic mice.
    Murphy KL; Kittrell FS; Gay JP; Jäger R; Medina D; Rosen JM
    Oncogene; 1999 Nov; 18(47):6597-604. PubMed ID: 10597264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperative induction of mammary tumorigenesis by TGFalpha and Wnts.
    Schroeder JA; Troyer KL; Lee DC
    Oncogene; 2000 Jun; 19(28):3193-9. PubMed ID: 10918574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors.
    Wu Y; Cui K; Miyoshi K; Hennighausen L; Green JE; Setser J; LeRoith D; Yakar S
    Cancer Res; 2003 Aug; 63(15):4384-8. PubMed ID: 12907608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted expression of des(1-3) human insulin-like growth factor I in transgenic mice influences mammary gland development and IGF-binding protein expression.
    Hadsell DL; Greenberg NM; Fligger JM; Baumrucker CR; Rosen JM
    Endocrinology; 1996 Jan; 137(1):321-30. PubMed ID: 8536631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBX causes cyclin D1 overexpression and development of breast cancer in transgenic animals that are heterozygous for p53.
    Klein A; Guhl E; Tzeng YJ; Fuhrhop J; Levrero M; Graessmann M; Graessmann A
    Oncogene; 2003 May; 22(19):2910-9. PubMed ID: 12771941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
    Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
    Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice.
    Jäger R; Herzer U; Schenkel J; Weiher H
    Oncogene; 1997 Oct; 15(15):1787-95. PubMed ID: 9362445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesis.
    Li M; Lewis B; Capuco AV; Laucirica R; Furth PA
    Oncogene; 2000 Feb; 19(8):1010-9. PubMed ID: 10713684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of ionizing radiation and genetic background on mammary tumorigenesis in p53-deficient mice.
    Backlund MG; Trasti SL; Backlund DC; Cressman VL; Godfrey V; Koller BH
    Cancer Res; 2001 Sep; 61(17):6577-82. PubMed ID: 11522657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SV40 small t-antigen prevents mammary gland differentiation and induces breast cancer formation in transgenic mice; truncated large T-antigen molecules harboring the intact p53 and pRb binding region do not have this effect.
    Goetz F; Tzeng YJ; Guhl E; Merker J; Graessmann M; Graessmann A
    Oncogene; 2001 Apr; 20(18):2325-32. PubMed ID: 11402328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic mechanisms affect mutant p53 transgene expression in WAP-mutp53 transgenic mice.
    Krepulat F; Löhler J; Heinlein C; Hermannstädter A; Tolstonog GV; Deppert W
    Oncogene; 2005 Jul; 24(29):4645-59. PubMed ID: 15870706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammary development and tumorigenesis in mice expressing a truncated human Notch4/Int3 intracellular domain (h-Int3sh).
    Raafat A; Bargo S; Anver MR; Callahan R
    Oncogene; 2004 Dec; 23(58):9401-7. PubMed ID: 15531924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
    Akli S; Van Pelt CS; Bui T; Multani AS; Chang S; Johnson D; Tucker S; Keyomarsi K
    Cancer Res; 2007 Aug; 67(15):7212-22. PubMed ID: 17671189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inability of overexpressed des(1-3)human insulin-like growth factor I (IGF-I) to inhibit forced mammary gland involution is associated with decreased expression of IGF signaling molecules.
    Hadsell DL; Alexeenko T; Klimentidis Y; Torres D; Lee AV
    Endocrinology; 2001 Apr; 142(4):1479-88. PubMed ID: 11250928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In wap-ras transgenic mice, tumor phenotype but not cyclophosphamide-sensitivity is affected by genetic background.
    Nielsen LL; Gurnani M; Catino JJ; Tyler RD
    Anticancer Res; 1995; 15(2):385-92. PubMed ID: 7763010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.